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Identifying cis-regulatory elements is important to
understanding how human pancreatic islets modu-
late gene expression in physiologic or pathophysio-
logic (e.g., diabetic) conditions. We conducted
genome-wide analysis of DNase I hypersensitive
sites, histone H3 lysine methylation modifications
(K4me1, K4me3, K79me2), and CCCTC factor
(CTCF) binding in human islets. This identified
18,000 putative promoters (several hundred
unannotated and islet-active). Surprisingly, active
promotermodificationswere absent at genes encod-
ing islet-specific hormones, suggesting a distinct
regulatory mechanism. Of 34,039 distal (nonpro-
moter) regulatory elements, 47% are islet unique
and 22% are CTCF bound. In the 18 type 2 diabetes
(T2D)-associated loci, we identified 118 putative
regulatory elements and confirmed enhancer activity
for 12 of 33 tested. Among six regulatory elements
harboring T2D-associated variants, two exhibit
significant allele-specific differences in activity.
These findings present a global snapshot of the
human islet epigenome and should provide func-
tional context for noncoding variants emerging from
genetic studies of T2D and other islet disorders.
INTRODUCTION
Type 2 diabetes (T2D) is a complex metabolic disorder that
accounts for 85%–95% of all cases of diabetes and afflicts
hundreds of millions of people worldwide (http://www.
diabetesatlas.org/content/diabetes). It is a leading cause of
substantial morbidity and is characterized by defects in insulin
sensitivity and secretion resulting from the progressive dysfunc-Cell Mtion and loss of b cells in the pancreatic islets of Langerhans
(Butler et al., 2007; Muoio and Newgard, 2008). Both genetic
predisposition and environmental factors contribute to these islet
defects. Islets constitute 1%–2% of human pancreatic mass
(Joslin and Kahn, 2005) and are composed of five endocrine
cell types that secrete different hormones: a cells (glucagon),
b cells (insulin), d cells (somatostatin), PP cells (pancreatic poly-
peptide Y), and 3 cells (ghrelin). These cells sense changes in
blood glucose concentration and respond by modulating the
activity of multiple pathways, including insulin and glucagon
secretion, to maintain glucose homeostasis (Joslin and Kahn,
2005). Several key transcription factors (TFs) that regulate these
responses are known (Oliver-Krasinski and Stoffers, 2008).
However, efforts to identify cis-regulatory elements upon which
these and other factors act have been restricted primarily to
promoter regions at specific loci (e.g., INS, PDX1) (Brink, 2003;
Ohneda et al., 2000).
Results from genome-wide association studies (GWAS) of
type 1 diabetes (T1D) (Barrett et al., 2009), T2D (reviewed in
Prokopenko et al., 2008), and related metabolic traits (Dupuis
et al., 2010; Ingelsson et al., 2010; Prokopenko et al., 2009)
suggest that genetic variation in cis-regulatory elements may
play an important role in b cell (dys)function and diabetes
susceptibility (De Silva and Frayling, 2010). Of the 18 most
strongly associated single-nucleotide polymorphisms (SNPs) in
each of the T2D-associated loci, only 3 are missense variants;
the remaining are noncoding (Prokopenko et al., 2008). Further-
more, there is evidence for allele-specific effects of two T2D-
associated SNPs on the islet expression level of nearby genes
(TCF7L2 [Lyssenko et al., 2007] and MTNR1B [Lyssenko et al.,
2009]). However, the dearth of annotation of functional regula-
tory elements has limited the capacity to investigate the role of
regulatory variation in complex diseases such as T2D.
Recent characterization of histone modifications and DNase
hypersensitivity in cultured cells has identified chromatin signa-
tures predictive of regulatory elements and actively transcribed
regions (Boyle et al., 2008; Guenther et al., 2007; Heintzman
et al., 2007). The data generated so far suggest that regulatoryetabolism 12, 443–455, November 3, 2010 ª2010 Elsevier Inc. 443
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Figure 1. Analysis of DNase I Hypersensitive Sites in the Islet Genome
(A) Distribution of DNase I-hypersensitive (DHS) peaks across five genomic annotation sets. ‘‘Promoter’’ denotes proximal regions 5 kb upstream of RefSeq tran-
scription start sites (TSSs) that do not overlap the TSS. ‘‘Exonic’’ represents regions that overlap at least one base with an exon.
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Epigenomic Analysis of Human Pancreatic Isletselement location and usage vary substantially among cell types
(Heintzman et al., 2009; Xi et al., 2007). Also, extensive chromatin
profiling has been conducted in very few human primary
tissues to date (Bhandare et al., 2010). In this study, we describe
a comprehensive genome-wide epigenomic map of unstimu-
lated human pancreatic islets. Using DNase- and ChIP-seq
approaches, we identified DNase I-hypersensitive sites that
mark regions of open chromatin, loci enriched for active histone
H3 lysine methylation modifications (H3K4me1, H3K4me3,
and H3K79me2), and binding sites for the insulator CCCTC-
binding factor (CTCF). These profiles provide a detailed
chromatin snapshot of regulatory elements and actively tran-
scribed units in the islet. Moreover, they identify regulatory
elements harboring T2D-associated variants in 6/18 loci. These
data provide a valuable resource for understanding and investi-
gating cis-regulation in the human islet and for discovering regu-
latory elements that may play an important role in diabetes
susceptibility.
RESULTS
Genome-wide Characterization of Open Chromatin
in the Human Pancreatic Islet
Active regulatory elements reside in open chromatin regions
hypersensitive to DNase I digestion (ENCODE Project Consor-
tium, 2007; Boyle et al., 2008; Crawford et al., 2004; Hesselberth
et al., 2009; Sabo et al., 2004). To identify all DNase-hypersensi-
tive sites (DHS) in the human pancreatic islet, we performed
DNase-seq (Boyle et al., 2008) and identified regions of the
genome with significant enrichment of sequence reads using
the MACS algorithm (Zhang et al., 2008) (Experimental Proce-
dures). This approach identified 101,326 human islet DHS peaks
(Table S1) covering 27 million bases (1% of the human
genome). Consistent with observations in CD4+ T cells (Boyle
et al., 2008), a substantive fraction of islet DHS peaks (23%,
n = 23,408) span annotated RefSeq transcription start sites
(TSS) or are within regions 5 kb upstream (Promoter), but the
majority reside within currently unannotated genomic regions
that may harbor functional distal regulatory elements
(Figure 1A). Peaks at TSSs are significantly longer and more
intense than those at all other loci (Figure 1B). This observation
supports the view that regions around TSSs are generally more
susceptible to DNase I digestion than putative non-TSS regula-
tory elements (Boyle et al., 2008).(B) Average length (teal) and intensity (yellow) of DHS peaks across five genomic a
longer and more intense than those elsewhere (**, two-tailed paired Student’s t t
greater than the sample average due to highly skewed distributions, but error ba
(C) Sequence and structure constraint at DHS. DHS peaks at RefSeq TSSs are u
brate conservation scores) than intronic and intergenic DHS peaks. A large major
constraint (assessed by the Chai algorithm) (Parker et al., 2009).
(D) Comparison of islet DHSpeakswith peaks from four different human cell lines.
human islet relative to each of the other four human cell types or all of them comb
not located at RefSeq TSSs. Varying levels of similarity across cell types may be
and/or sequencing depth.
(E) Overlap between DHS peaks and formaldehyde-assisted isolation of regulato
than elsewhere (**, Fisher’s exact test < 10100).
(F) Logarithm-based distribution of the distance to the nearest distal DHS (d-DHS
tation of peaks in the 100–1000 bp range (clustered) relative to Gaussian expe
(Fisher’s exact test, p = 2.7 3 109). Comparison of d-DHS, FAIRE, and GLITR l
Cell MApproximately 48% (n = 48,777) of all DHS peaks overlap
phastCons vertebrate conserved elements (Siepel et al., 2005)
(Figure 1C). Notably, 87% (10,348/11,829) of peaks at TSSs
overlap phastCons elements, compared to 43% (38,429/
89,497) at non-TSS loci (Figure 1C). This difference remains
even after accounting for the longer peaks at TSSs (data not
shown), supporting the model that TSS-proximal regions evolve
under stronger sequence constraint than distal regulatory
elements (Boyle et al., 2008). A recent study developed an algo-
rithm (Chai) for topography-informed conservation analysis,
which identified2-foldmore bases in the human genome under
evolutionary constraint compared to sequence-based methods
(Parker et al., 2009). Accordingly, 1.5 times as many (76%)
islet DHS peaks overlap these structurally constrained regions
(Figure 1C).
To determine the extent of cell-type specificity of our islet DHS
peaks, we obtained DNase-seq data generated for four different
human cell lines: GM12878, K562, HeLa-S3, and HepG2 (Duke
DNase, ENCODE Project Consortium, 2007). We identified
DHS peaks for these cell lines (Experimental Procedures) and
found that roughly half the islet peaks are shared with each indi-
vidual nonislet cell type. Notably, 35% (n = 34,273) are
completely unique to the islet (Figure 1D). Almost all (99%) of
these islet-unique peaks do not overlap RefSeq TSSs, which is
consistent with the model that tissue-specific gene expression
patterns are governed largely by distal cis-regulatory elements
(Heintzman et al., 2009).
An independent method to map open chromatin is formalde-
hyde-assisted isolation of regulatory elements (FAIRE) (Giresi
et al., 2007). Recently, this approach was used for human islets
to identify three sets of candidate peaks, including ‘‘stringent’’
(n = 9887) and ‘‘liberal’’ (n = 100,715) peaks (Gaulton et al.,
2010). Approximately 75% of the ‘‘stringent’’ islet FAIRE peaks
overlap DHS peaks. However, this corresponds to only 7360
peaks, which is far fewer than the predicted number of functional
regulatory elements genome-wide (ENCODE Project Consor-
tium, 2007). The overlap is significantly greater at TSSs com-
pared to non-TSSs (97% versus 65%) (Figure 1E). Comparing
DHS peaks to the set of ‘‘liberal’’ islet FAIRE peaks, the overlap
drops to 29%. Therefore, the two approaches seem to identify
distinct sets of non-TSS regulatory elements. Because it is diffi-
cult to assess the extent to which the dissimilarity between DHS
and FAIRE data is explained by differences in islet sample purity,
preparation methods, false positive signals, or populationnnotation sets. Peaks at RefSeq transcription start sites (TSSs) are significantly
est, p value < 10100). Error bars represent SD (SD measurements were often
rs were cut off at zero for visualization).
nder substantially greater sequence constraint (assessed by phastCons verte-
ity of DHS peaks within all genomic annotation sets are under strong structural
Each data point represents the fraction of total peaks (n = 101,326) unique to the
ined (Union of all 4). Roughly 35% are unique to the islet, and 99% of these are
at least partially explained by differences in the stage of cellular differentiation
ry elements (FAIRE) peaks. The overlap is significantly greater at RefSeq TSSs
) peak among all d-DHS peaks. The blue box indicates an increased represen-
ctation (red curve). This range is significantly enriched for islet-unique peaks
ocations is found in Figure S1.
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Epigenomic Analysis of Human Pancreatic Isletsdiversity (McDaniell et al., 2010), more controlled comparisons of
these techniques will be necessary to elucidate inherent prefer-
ences of each for specific classes of open chromatin.
Though many of the mechanistic details are not clear, it is
widely accepted that distal and promoter regulatory elements
can exert coordinated control of gene transcription via physical
interactions (Dekker, 2003; Miele and Dekker, 2008). Therefore,
it has been hypothesized that distal cis-regulatory elements
may cluster together to form functional modules (Blanchette
et al., 2006). To assess the clustering of putative islet-active
distal cis-regulatory elements, we filtered from the islet DHS
peaks (n = 101,326) the regions that may represent promoters
to identify a set of high-confidence distal peaks (d-DHS, n =
34,039) (Table S2 and Figure S1 and Experimental Procedures).
For each d-DHS peak, we computed the distance to the nearest
d-DHS peak and observed an increased representation in the
100–1000 bp range (n = 7652) relative to the expectation
from a normal distribution (Figure 1F). Furthermore, this set is
significantly enriched for islet-unique peaks (p = 2.7 3 109).
Genome-wide Characterization of TSSs in the Islet
Genome via H3K4me3 ChIP-Seq
To characterize human islet TSSs, we conducted ChIP-seq anal-
ysis of histone 3 lysine 4 trimethylation (H3K4me3) in four
different human islet samples. H3K4me3 is enriched at CpG
islands (Bernstein et al., 2007), TSSs (Li et al., 2007), and sites
of active transcription (Kouzarides, 2007). Enriched regions
present in all four islet samples, but absent from three mock-IP
(anti-GFP) experiments, were designated as ‘‘H3K4me3 peaks.’’
This method identified 18,163 human islet H3K4me3 peaks
(Table S3) covering 1% of the genome.
As expected, approximately two-thirds (n = 11,973) of
H3K4me3 peaks overlap RefSeq TSSs (Figure 2A). Greater
than 70% of the remaining, unannotated peaks (n = 6190) over-
lap computationally predicted TSSs and/or CpG islands.
However, the significantly lower average length and intensity of
unannotated H3K4me3 peaks compared to those at RefSeq
TSSs (Figure 2B) suggests that at least some of these peaks
may indicate weakly active TSSs, inactive but poised TSSs
(Barski et al., 2007; Guenther et al., 2007; Mikkelsen et al.,
2007), remnants of transcriptional activity from the develop-
mental past or prior environmental stimulation (Barski et al.,
2009), or chromatin looping with distal regulatory regions. While
a subset of peaks could be false-positive signals, this is unlikely,
as it would require a technical artifact that is consistent across all
four islet samples.
Previous genome-wide profiling studies have reported a posi-
tive correlation between the intensity of H3K4me3 signal and
gene expression level (Barski et al., 2007; Guenther et al.,
2007). To test this observation in islets, we downloaded human
islet gene expression data from http://T1Dbase.org (Kutlu
et al., 2009), partitioned gene expression into quintiles, and
computed the average H3K4me3 signal length and intensity at
the TSSs of genes within each bin. Although the average
H3K4me3 peak length and intensity monotonically increases
with gene expression, there is great variability within each
expression bin (Figure 2C). Surprisingly, of the 245 most highly
islet-expressed genes in this data set, 18% (n = 45) have either
no or extremely low associated H3K4me3 signal. Notably, 71%446 Cell Metabolism 12, 443–455, November 3, 2010 ª2010 Elsevier(32/45) also lacked a DHS peak (data not shown). Gene ontology
(GO) analysis revealed that these 45 genes are most significantly
enriched for themolecular function of hormone activity (p = 0.029
after Bonferroni correction for multiple testing) (Experimental
Procedures). These genes include insulin (INS), glucagon
(GCG), islet amyloid polypeptide (IAPP), pancreatic polypeptide
preprotein (PPY), somatostatin (SST), and transthyretin (TTR).
We confirmed by quantitative RT-PCR that INS, GCG, and SST
are robustly expressed (Figure S2), so it is unlikely that low
H3K4me3 at these TSSs is due to technical artifacts or adverse
effects of the islet shipment or handling process. Because these
genes are <10 kb in length, we considered the possibility that
weak H3K4me3 signal is simply associated with short genes.
However, the proportion of short genes (<10 kb in length) within
the set of ‘‘most highly expressed with no/low H3K4me3 signal’’
(66.7%, 30/45) is not statistically different from the proportion of
short genes within the entire set of most highly expressed
(69.8%, 171/245). This result suggests that the transcriptional
regulation of islet hormones and other related, highly islet-
expressed genes occurs through a distinct mechanism as
compared to most other genes.
H3K4me3 ChIP-chip (human embryonic stem cells, hepato-
cytes, REH cells [Guenther et al., 2007]) or ChIP-seq (human
CD4+ T cells [Barski et al., 2007] and GM12878, HUVEC,
NHEK, K562, and HeLa cell lines [Broad Institute ChIP-seq,
Bernstein lab, ENCODE Project Consortium, 2007]) data are
available for nine different human cell types. Comparisons
between islet and each other cell type indicated that, on average,
10%–30% of the islet peaks are unique (Figure 2D). Not surpris-
ingly, this value drops to1.5% (n = 256) when comparedwith all
nine cell types together. Only 34 of the 256 islet-unique peaks
correspond to TSSs of annotated RefSeq genes, and these are
enriched for known pancreatic b cell functions such as secretion
(p = 9.33 103) and Ca2+-dependent exocytosis (p = 6.63 103)
(Table 1). Furthermore, several of the genes (SLC30A8, GCK)
harbor genetic variants that confer significant risk for T2D and
elevated plasma fasting glucose levels (Dupuis et al., 2010;
Ingelsson et al., 2010; Prokopenko et al., 2008, 2009). The
remaining 222 islet-unique peaks may represent alternative
TSSs of genes with function in developing and/or mature islets
or TSSs of unannotated coding or noncoding transcription units.
Identification of Unannotated Islet-Active TSSs
H3K4me3 peaks in unannotated genomic space (n = 6190) are
TSS candidates. Because H3K4me3 may also be enriched at
inactive TSSs (Guenther et al., 2007), we adopted a two-step
approach to identify the subset of these 6190 peaks that are
likely to be active in the human islet (Figure S3A). First, we devel-
oped an algorithm that uses DHS peaks to assign directionality
to H3K4me3 peaks (Experimental Procedures). DHS peaks
tend to be sharply focused around the TSS, while H3K4me3
peaks are broader and extend well into the body of the transcrip-
tion unit. We hypothesized that the location of the DHS peak
relative to the H3K4me3 peak could predict the directionality
of the underlying gene. Using the strongest DHS peak within
an H3K4me3 peak, this simple algorithm performed at 90%
accuracy on annotated RefSeq genes known to be expressed
in the human islet (Experimental Procedures). Interestingly, the
majority (80%) of the incorrectly assigned TSSs (based onInc.
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Figure 2. Analysis of Histone 3 Lysine 4 Trimethylation Loci in the Islet Genome
(A) Distribution of H3K4me3 peaks across five genomic annotation sets as described in Figure 1A. Two-thirds of the peaks span RefSeq transcription start sites
(TSSs, left pie chart). Non-RefSeq H3K4me3 peaks are enriched for computationally predicted TSS and/or CpG islands (right pie chart). Additional information is
provided in Figure S3.
(B) Average length (purple) and intensity (blue) of H3K4me3 peaks across five genomic annotation sets as described in Figure 1B. The average length and intensity
of peaks is significantly higher at TSSs (**, two-tailed paired Student’s t test, p value < 10100). Error bars represent SD.
(C) Relationship between average H3K4me3 peak length (yellow)/intensity (purple) and average gene expression level. Error bars represent SD.
(D) Comparison of islet H3K4me3 peaks with peaks from nine different human cell types. Each data point represents the fraction of total peaks (n = 18,163) unique
to the human islet relative to each of the other nine human cell types or all of them combined (Union of all 9). 1.5% of the peaks are unique to the islet. Varying
levels of similarity across cell types may be at least partially explained by differences in the stage of cellular differentiation and/or sequencing depth.
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Epigenomic Analysis of Human Pancreatic Isletscurrent annotation) harbored multiple DHS peaks, positioned on
either end of the H3K4me3 peak. These H3K4me3 peaks are
slightly (200 nt) longer than those for which the orientation
was correctly assigned, increasing the likelihood of overlapping
non-TSS-related DHS peaks, which can confound the prediction
algorithm. Many of these non-TSS DHS peaks may correspond
to CTCF-binding sites that are located on the opposite side of
the DHS with respect to the TSS (Boyle et al., 2008) and RNA
polymerase (Pol) III-bound loci found in chromatin domainsCell Moccupied by Pol II and associated with enhancer-binding factors
(Oler et al., 2010). We observe examples of each case in our data
set (Figure S4).
Second, we performed ChIP-seq to profile genome-wide
histone 3 lysine 79 dimethylation (H3K79me2), which is enriched
in actively transcribed regions (Guenther et al., 2007). If the rela-
tive density of H3K79me2 reads on either side of an H3K4me3
peak was consistent with its predicted directionality (as deter-
mined from the pattern of the DHS and H3K4me3 signal), thenetabolism 12, 443–455, November 3, 2010 ª2010 Elsevier Inc. 447
Table 1. Examples of Islet-Unique H3K4me3 Peaks
Gene Symbol Relevance to Islet Biology
GCK Involved in glucose metabolism
T2D GWAS locus (Dupuis et al., 2010)
Harbors an islet-specific promoter (Magnuson, 1990)
SLC30A8 Involved in cation (Zn+) transport important for insulin
secretion (Chimienti et al., 2004)
T2D GWAS locus (Prokopenko et al., 2008)
Exhibits islet-specific expression (Chimienti et al., 2004)
REG1A Derived from regenerating islets (Terazono et al., 1988)
FFAR1 Exhibits islet-specific expression (Bartoov-Shifman
et al., 2007)
Regulates insulin secretion (Itoh et al., 2003)
SYT4 Involved in Ca2+-dependent trafficking and exocytosis
of secretory vesicles (Tsuboi and Rutter, 2003)
KCNK16 Exhibits pancreas-specific expression
(Girard et al., 2001)
ELAVL4 Regulates cell proliferation (Joseph et al., 1998)
UCN3 Regulates glucose-stimulated insulin secretion
(Li et al., 2007)
PRSS1 Harbors mutations that underlie hereditary pancreatitis
and pancreatic cancer (Teich et al., 1998)
Nine examples among the 34 islet-unique peaks that are at RefSeq tran-
scription start sites (TSSs). The corresponding genes have known
pancreatic islet function (such as insulin secretion), and some harbor
genetic variants that confer significant risk for type 2 diabetes
(SLC30A8 and GCK).
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Epigenomic Analysis of Human Pancreatic Isletsthe underlying TSSwas classified as islet active. Intragenic TSSs
are difficult to assess using this method, because the H3K79me2
signal may be due to transcription from an upstream TSS.
Restricting the analysis to intergenic space, we identified 263
candidates for unannotated, islet-active TSSs (Table S4), of
which 75% (n = 196) overlapCpG islands and/or computationally
predicted TSSs (Figure S3A). These candidates include islet-
active TSSs for noncoding RNAs such as the let-7a-1 cluster
of microRNAs (Figure 3A) and the miR-1179/miR-7-2 cluster
(Figure S3B). We also identified putative alternative TSSs for
genes with important islet function such as pancreatic peptidyl-
glycine a-amidating mono-oxygenase (PAM), which encodes for
an islet secretory granule membrane protein (Figure 3B). Finally,
we identified an active promoter locus that is contained within
a recently reported T1D-associated region on chromosome 12
(index SNP rs1701704). This promoter could underlie an unanno-
tated transcript or could be an alternative promoter for the down-
stream gene Ikaros family zinc finger 4 (IKZF4) (Figure S3C),
which is considered a strong functional candidate for T1D (Hako-
narson et al., 2008).
Identification of Distal cis-Regulatory Elements
Sites bound by the CTCF are an important class of cis-regulatory
elements that can mediate insulator or other regulatory activities
(Phillips and Corces, 2009). To generate a genome-wide CTCF-
binding site profile in the human islet, we performed ChIP-seq
and designated enriched regions as ‘‘CTCF peaks’’ (n =
21,304) (Table S5 and Experimental Procedures). We assessed
the genomic distribution of peaks (Figure 4A), computed the448 Cell Metabolism 12, 443–455, November 3, 2010 ª2010 Elsevieraverage peak intensity/length across various genomic cate-
gories (Figure 4B), and identified the most significantly overrep-
resented motif within the peaks using MEME (Figure 4C and
Supplemental Experimental Procedures). The results corrobo-
rate those from previously described studies in other cell types
(Kim et al., 2007; Jothi et al., 2008; Cuddapah et al., 2009).
Further, only 0.6% (n = 123) of CTCF peaks were islet unique
(Figure 4D). Finally, we observed that among the 77% of CTCF
peaks that overlap 22% of DHS peaks, the CTCF peaks are
positioned near the center of the DHS peak with a slight 50 shift
(Figure 4E).
Previous studies have observed depletion of monomethylated
histone 3 lysine 4 (H3K4me1) at TSSs and enrichment at putative
enhancers such as distal STAT1 and EP300 sites (ENCODE
Project Consortium, 2007; Heintzman et al., 2007, 2009; Robert-
son et al., 2008) and nonpromoter DHS (Barski et al., 2007;
Robertson et al., 2008; Wang et al., 2008). To profile H3K4me1
across the human islet genome, we repeated the ChIP-seq
strategy described above for three islet samples. We computed
the average ratio of the density of extended H3K4me1 sequence
reads in DHS peaks at RefSeq TSSs (t-DHS, n = 11,829) and
d-DHS peaks (n = 34,039) (Experimental Procedures) to the
density in flanking control regions that do not harbor DHS signal
(Experimental Procedures). t-DHS peaks are significantly
depleted for H3K4me1, whereas d-DHS peaks are significantly
enriched (Figure 5). Further, there was no significant difference
in H3K4me1 enrichment between CTCF-positive and CTCF-
negative d-DHS. Although we detected depletion of H3K4me1
at t-FAIRE peaks, there was no enrichment at d-FAIRE peaks
(Figure 5).
We did not detect dramatically different H3K4me1 enrichment
levels between intergenic and intragenic d-DHS peaks (Fig-
ure S5). Interestingly, although the average H3K4me3 read
density in d-DHS peaks was 3-fold less than that of
H3K4me1, d-DHS peaks were still enriched for H3K4me3 signal
relative to flanking control regions (Figure S5). These observa-
tions are consistent with the previous finding that although
H3K4me1 often marks distal regulatory regions, a substantial
portion is also associated with H3K4me3 signal (Robertson
et al., 2008). Overall, the enrichment of active histone modifica-
tions suggests that islet d-DHS peaks are strong candidates for
putative regulatory elements. Fifty published index SNPs (http://
www.genome.gov/gwastudies/) and their linkage disequilibrium
partners (r2 > 0.6) for diabetes (T1D, T2D) and related quantita-
tive traits (fasting glucose, fasting insulin) are found within
500 bp of nonpromoter d-DHS peaks (Table S9 and Experi-
mental Procedures), suggesting that these SNPs may contribute
to diabetes or altered islet physiology by modulating regulatory
element activity.
Application of Chromatin Profiles to T2D
Susceptibility Loci
To identify regulatory elements and transcripts that may underlie
molecular mechanisms of T2D, we analyzed the chromatin
profiles in the 18 GWAS-derived genomic loci conferring risk
for T2D (Prokopenko et al., 2008). The genomic boundaries
of each association signal (Table S6) were defined by the Spotter
algorithm (Experimental Procedures). The chromatin profiles do
not predict any alternative promoters or unannotated/noncodingInc.
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Figure 3. Identifying Unannotated Islet-Active Transcription Start Sites
(A) Candidate islet-active TSS for the primary transcript of the ubiquitous let-7a-1/7d/7f-1microRNA cluster. The TSS (red box; DHS+, H3K4me3+, H3K4me1) is
10 kb upstream of the 50-most microRNA in the cluster, and the full-length primary transcript (H3K79me2+) of35 kbmatches a known EST (BSG326593). This
EST likely represents a noncoding RNA primary transcript from which the let-7 cluster of miRNAs is processed (Marson et al., 2008). The strategy for predicting
TSSs is shown in Figure S3A.
(B) Two candidate islet-active alternative TSSs (red boxes) for the gene PAM, which encodes an islet secretory granule membrane protein. One of the candidate
TSSs is also islet unique and occurs between the annotated TSS and an unannotated islet-active TSS. Examples of confounding factors for predicting islet-active
TSSs are shown in Figure S4.
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Epigenomic Analysis of Human Pancreatic Isletstranscripts in these regions. However, they do identify 118
d-DHS peaks, which represent putative distal regulatory ele-
ments (Table S7 and Experimental Procedures). About one-
quarter of these elements (n = 28) are bound by CTCF in the islet.
Six of the 118 elements contain one or more T2D-associated
SNPs (index SNP or SNP with r2 > 0.6) (Table S8). These six
include a previously identified element containing the index
SNP rs7903146 in the TCF7L2 locus (Gaulton et al., 2010). TheCell Mremaining five map to the IGF2BP2, KCNQ1, WFS1, FTO, and
CDC123/CAMK1D loci. Only the CDC123/CAMK1D element is
bound by CTCF in the islet.
Validation of Putative Islet Regulatory Elements
in T2D Loci
To determine whether predicted regulatory elements in the islet
can function as enhancers, we cloned two classes of elementsetabolism 12, 443–455, November 3, 2010 ª2010 Elsevier Inc. 449
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Figure 4. Profiling of Binding Sites for the CCCTC-Binding Factor
(A) Distribution of CTCF peaks across five genomic annotation sets as described in Figure 1A.
(B) Average length (orange) and intensity (green) of CTCF peaks across five genomic annotation sets is fairly uniform. Error bars represent SD.
(C) Motif determined by MEME (Bailey and Elkan, 1994) using the top 10% of CTCF peaks.
(D) Comparison of islet CTCF peaks with peaks from five different cell types. Each data point represents the fraction of total peaks (n = 21,304) unique to the
human islet relative to each of the other five human cell types or all of them combined (Union of all 5). Less than 1% of the peaks are unique to the islet (n =
123). Varying levels of similarity across cell typesmay be at least partially explained by differences in the stage of cellular differentiation and/or sequencing depth.
(E) Positioning of CTCF peaks relative to the center of overlapping DHS peaks (red line). Almost all CTCF peaks that overlap DHS peaks are within 200 bp of the
DHS peak center.
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(Figure 6): those bound by CTCF (‘‘C,’’ n = 11) and those that
are not (‘‘P,’’ n = 33). We also cloned a number of non-DHS,
non-CTCF controls (‘‘N,’’ n = 15). Because human islet cell lines450 Cell Metabolism 12, 443–455, November 3, 2010 ª2010 Elsevierare not available, we tested these elements for enhancer activity
in murine pancreatic MIN6 (Figure 6A) and HeLa (Figure 6B) cell
lines. Only 15% (4/26) of the negative controls exhibited
enhancer activity in any orientation or cell type (9% [1/11] ofInc.
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Figure 5. Representation Analysis of Histone H3 Lysine 4 Monome-
thylation in Candidate Regulatory Regions
DNase I-hypersensitive site (DHS) and formaldehyde-assisted isolation of
regulatory elements (FAIRE) peaks at RefSeq TSSs (t-DHS and t-FAIRE,
respectively) are significantly depleted for H3K4me1 signal (**, two-tailed
paired Student’s t test, p < 0.005), and DHS peaks at distal candidate regula-
tory elements (d-DHS) are enriched for H3K4me1 signal (*, two-tailed paired
Student’s t test, p < 0.01). Error bars represent SD among three islet samples.
FAIRE data were obtained from Gaulton et al. (2010). Representation analysis
of additional histone modifications is shown in Figure S5.
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Epigenomic Analysis of Human Pancreatic Islets‘‘C’’ elements and 20% [3/15] of ‘‘N’’ elements) (Figures 6A and
6B). In contrast, 2.5-fold more ’’P’’ elements demonstrated
enhancer activity (12/33). This positive rate (36.4%) is compa-
rable to that of predicted HeLa enhancers (Heintzman et al.,
2009) that exhibited increased luciferase activity in our HeLa
reporter assays (38.5%, 5/13).
Four of 12 ‘‘P’’ elements exhibiting enhancer activity (P4,
KCNJ11/ABCC8; P12, TCF7L2; P17, WFS1; P20, HHEX/IDE)
are unique to the islet; one of these (P17, WFS1) is also unde-
tected by at least three other methods for the prediction of
regulatory element potential: PReMod (Ferretti et al., 2007),
phastCons (Siepel et al., 2005), and islet-FAIRE (Gaulton
et al., 2010). The average H3K4me1 enrichment among the 12
d-DHS peaks in the elements exhibiting enhancer activity was
similar to that computed for all d-DHS (1.3-fold) (Figure 6C).
However, there was large variation in H3K4me1 enrichment
among individual elements (0.6- to 3.4-fold), with only 3/12
enriched above baseline (1.0) (Figure 6C).
Allele-Specific Analysis of Five Regulatory Elements
Containing T2D-Associated SNPs
Five ‘‘P’’ elements tested contain T2D-associated SNPs (P9,
IGF2BP2; P12, TCF7L2; P17, WFS1; P21, KCNQ1; P23, FTO)
(Figures 6A and 6B). Notably, four out of the five elements (all
except P9) exhibited enhancer activity in at least one orientation
and cell type tested. To assess allele- or haplotype-specific
effect(s) of T2D-associated variants on enhancer activity, we
cloned these four regions from the genomic DNA of individuals
with risk and nonrisk genotypes/haplotypes and compared lucif-
erase reporter activity (Figures 6D and S6A). We confirmed
significantly stronger enhancer activity for the TCF7L2 elementCell M(P12) containing the rs7903146 risk allele relative to the nonrisk
allele (3-fold) (Figure 6D) (Gaulton et al., 2010). TCF7L2 allelic
enhancer effects were specific to the MIN6 cell line (Figure 6D,
compare MIN6 and HeLa). Sequencing of the TCF7L2 inserts
from each haplotype revealed two variant bases, a novel variant
(C/G at Chr10:114,747,977; hg18) and rs7903146; only
rs7903146 mediated allele-specific effects on enhancer activity
(Figure 6D, compare Risk to Nonrisk and Nonrisk(m)) (Fig-
ure S6B). We also identified a haplotypic effect on enhancer
activity for the WFS1 element (P17), which contains four SNPs
(rs4689397, rs6823148, rs881796, and rs4234731). The risk
haplotype exhibited 30% lower activity than nonrisk in HeLa
cells (Figure 6D).
DISCUSSION
In this study, we describe themost comprehensive characteriza-
tion to date of the epigenomic profile of unstimulated human
pancreatic islets. Using DNase- and ChIP-seq techniques, we
profiled open chromatin, CTCF-binding sites, H3K4me3,
H3K4me1, and H3K79me2 across the entire genome in human
islets. Integrated analysis of these large-scale data sets identi-
fied 18,000 putative TSSs, 30% of which were previously
unannotated by RefSeq. Further computational genomic anal-
yses revealed that at least several hundred of these are
islet-active TSSs, including those for major islet miRNAs previ-
ously implicated in the control of glucose homeostasis (Lynn,
2009). Interestingly, active chromatin marks (H3K4me3, DHS,
H3K79me2) were absent from a subset of highly islet-expressed
genes, including those encoding islet-specific hormones (INS,
GCG, SST, IAPP, PPY, and TTR). This observation suggests
that some genes critical for islet function have an unconventional
promoter chromatin signature, indicative of a unique transcrip-
tional control mechanism. Mutskov and Felsenfeld (2009) have
proposed such a model based on detailed analysis of the INS
locus in human islets.
We also identified 34,000 candidate distal regulatory
elements in human islets. A substantial number of these putative
elements were clustered (<1000 bp from each other). Compari-
sons with other cell types indicated that these clustered
elements are significantly enriched for islet-unique sites and
thus may represent islet-specific regulatory modules worthy of
more extensive future investigation. Based on CTCF-binding
profiles, 22% of the 34,000 candidate distal regulatory
elements are predicted insulator sites. Previous studies have
reported that the H3K4me1 signal is enriched in distal regulatory
elements (Heintzman et al., 2007, 2009). Though our analyses
confirm this finding in aggregate, we show that H3K4me1 enrich-
ment may not be a reliable predictor of regulatory activity for
individual elements.
Fifty SNPs associated with islet-related diseases and traits
map to within 500 bp of a candidate nonpromoter regulatory
element. Focusing on T2D, 4 of the 12 elements that function
as enhancers in vitro (FTO, KCNQ1, TCF7L2, and WFS1 loci)
harbor T2D-associated SNPs, including two (TCF7L2 and
WFS1 loci) that exhibit significant allele-specific differences in
activity. These results suggest that altered enhancer activity
plays a role in the molecular mechanism underlying at least
a subset of T2D genetic association signals.etabolism 12, 443–455, November 3, 2010 ª2010 Elsevier Inc. 451
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Epigenomic Analysis of Human Pancreatic IsletsThese data sets should provide functional context for noncod-
ing variants identified through additional association, targeted
resequencing, or whole-genome sequencing studies. Further
analysis of the repertoire of regulatory elements in the human
islet will enhance the understanding of gene regulation in the islet
and should offer additional insight into the molecular mecha-
nisms that underlie diabetes susceptibility.
EXPERIMENTAL PROCEDURES
Human Islets
Fresh human pancreatic islets were obtained from the ICR Basic Science Islet
Distribution Program and National Disease Research Interchange (NDRI). Islet
viability and purity were assessed by the distribution centers and are shown
along with phenotypic/clinical information of each donor in Table S10. Islets
were warmed to 37C andwashedwith calcium- andmagnesium-free Dulbec-
co’s phosphate-buffered saline (Invitrogen; Carlsbad, CA) prior to crosslinking.
For chromatin immunoprecipitation (ChIP) studies, cells were crosslinked for
20 min in 1% formaldehyde at room temperature, frozen in liquid nitrogen,
and stored at 80C.
DNase-Seq and DHS Peak Identification
For DNase-seq experiments, fresh pancreatic islets were disaggregated to
achieve single-cell suspension. Islets were washed with prewarmed 1X PBS
once and resuspended with dissociation solution (1 ml of 1X PBS, 50 ml of
0.05 U/ml Dispase I stock solution [Roche; Indianapolis, IN]). Islet suspension
was transferred to a 6-well culture dish, incubated at 37C for 30 min, dissoci-
ated with a 2 ml sterile pipette, and incubated for another 30 min. This incuba-
tion-agitation cycle was repeated 4 or 5 times until >90% of islets were disag-
gregated into single cells. Cells were washed with prewarmed 1X PBS once
and prepared for DNase-seq experiments as previously described (Song
and Crawford, 2010). Libraries from three primary human islet samples
(Table S10) were sequenced using the Illumina GAII platform. Peaks were
identified using MACS (Supplemental Experimental Procedures) (Zhang
et al., 2008).
ChIP and Illumina GAII Sequencing
ChIP assays were carried out as previously described (Scacheri et al.,
2006), with the following modifications. Intact nuclei were isolated and
chromatin was sheared on ice using a Branson 450 Sonifier (constant duty
cycle, output 4, 12–16 cycles of 20 s sonicationwith 1min rest between cycles)
to a size of 200–1000 bp. Antibodies used for ChIP were anti-H3K4me3
(ab8580, Abcam; Cambridge, MA), anti-H3K4me1 (ab8895, Abcam), anti-
H3K79me2 (ab3594, Abcam), anti-CTCF (ab70303, Abcam; 07-729, Millipore;
Danvers, MA), and anti-GFP (sc-8334, Santa Cruz Biotechnology; Santa
Cruz, CA).
Islet ChIP-seq libraries were prepared and sequenced using the Illumina
GAII protocol and platform. The number of sequencing lanes, clusters, aligned
reads, repeat-filtered reads (no satellite reads), and unique starts is shown
for each islet and ChIP experiment in Table S12. MACS (Zhang et al., 2008)
was used to call H3K4me3 and CTCF peaks (Supplemental Experimental
Procedures).Figure 6. Luciferase Reporter Activity Validates Putative Enhancer Ele
(A) Relative luciferase activity of constructs in three element classes tested in MIN
dashed lines indicate 2.33 standard deviations (p = 0.01) (Heintzman et al., 2009) a
the forward or reverse orientations, respectively. Data represent the mean ±SD
d-DHS+/CTCF+ element; N, d-DHS/CTCF; P, d-DHS+/CTCF element. # ma
cate the luciferase activity for elements beyond the scale of the y axis; a.u. deno
(B) Relative luciferase activity of constructs in three element classes tested in He
(C) H3K4me1 representation in the 12 elements exhibiting enhancer activity. Tho
3/12 elements are above baseline (red line). Error bars represent SD among thre
(D) Relative luciferase activity of TCF7L2 (P12) andWFS1 (P17) elements in MIN6
T2D-associated SNPs. For TCF7L2, (m) denotes a mutation generated by site-dire
of three replicates each from at least two independent clones. **, two-tailed unpa
Cell MGenome-wide Analysis of Chromatin Marks
Perl and R scripts were written to perform the genomic characterization and
comparative analysis of DHS, H3K4me3, and CTCF peaks. Unless otherwise
noted, functional annotation data sets (including RefSeq and UCSC known
genes, predicted TSSs and bidirectional promoters, phastCons elements,
CpG islands, and ChIP-seq data sets) were downloaded from the UCSC Table
Browser on November 1, 2009 (http://genome.ucsc.edu/cgi-bin/hgTables).
For ‘‘computationally predicted TSSs,’’ both the Eponine and the Switch-
gear data sets from the UCSC Table Browser were utilized. Human pancreatic
islet gene expression data were downloaded from T1DBase (http://T1Dbase.
org), and expression data for other tissues were downloaded from BioGPS
Human U133A/GNF1H Gene Atlas (http://biogps.gnf.org/downloads/). Islet-
selective gene expression was defined as at least 3-fold greater expression
in the islet relative to any other tissue represented. Genome-wide results of
the Chai algorithm were determined according to the parameters in Parker
et al. (2009), and islet-FAIRE data sets were obtained from Gaulton et al.
(2010). GO analyses were performed using the web-based tool NIH DAVID
6.7 (http://david.abcc.ncifcrf.gov/). For the DHS peak clustering analysis
(Figure 1F) and the histone modification enrichment/depletion analysis
(Figures 5 and S5), we stringently defined d-DHS peaks as those that are
not within H3K4me3 peaks andR5 kb away from RefSeq TSSs, UCSC Known
Gene TSSs, Eponine or Switchgear computationally predicted TSSs, and CpG
islands, yielding 34,039 d-DHS. To select regulatory elements to test for
enhancer activity (Figure 6), the definition of d-DHS was slightly loosened
(R5 kb upstream and R1 kb downstream from known and predicted TSSs
and CpG islands). P values for statistical comparisons were computed using
either the two-tailed paired Student’s t test or the Fisher’s exact test. Details
of the remaining computational analyses are described in Supplemental
Experimental Procedures.
Molecular Cloning
Putative regulatory elements were amplified from human genomic DNA with
primers designed using PrimerTile (http://research.nhgri.nih.gov/tools/).
Element boundaries were determined by manual H3K4me1 profile inspection.
Coordinates of amplified elements and primer sequences for amplification are
found in Table S13. Putative regulatory elements were cloned using the
Gateway system (Invitrogen). Generation of Gateway-compatible vectors is
described in Supplemental Experimental Procedures. Variants of interest
were introduced using QuikChange Lightning (Stratagene; La Jolla, CA). Muta-
genesis primer sequences are available upon request. Mutagenesis was
confirmed by direct sequencing.
Transfection and Dual Luciferase Assays
Cells were seeded in 96-well plates (40,000 cells/well HeLa, 60,000 cells/well
MIN6) and cotransfected with 0.072 pmol Gateway-modified firefly (pGL 4.23,
Promega; Madison, WI) and 2 ng Renilla (pRL-TK, Promega) vectors using
Lipofectamine 2000 (Invitrogen). Two vector preparations per insert orientation
were tested. Transfections were performed in triplicate.
Cells were lysed in 13 passive lysis buffer (Promega) 36–48 hr posttransfec-
tion, and dual luciferase assays were run on a Centro/Centro XS3 Microplate
Luminometer LB 960 (Berthold; Bad Wildbad, Germany). Firefly values were
normalized to Renilla to control for differences in cell number or transfection
efficiency. Luciferase assays were performed in triplicate. For each element
tested, at least two independent vector preparations were used. Activity wasments
6 cells. Genomic locations of elements are found in Table S13. Blue and orange
bove the median activity of tested CTCF-bound regions for elements cloned in
of three replicates each for two separate clones (six total measurements). C,
rks elements containing T2D-associated SNPs. Numbers above the bars indi-
tes arbitrary units.
La cells. Data are analyzed and annotated as in (A).
ugh the overall average enrichment of H3K4me1 is 1.3-fold (green line), only
e islet samples.
(left panels) or HeLa (right panels) cells containing the risk or nonrisk alleles of
cted mutagenesis from the risk to nonrisk allele. Data represent the mean ±SD
ired Student’s t test, p < 0.01. Additional allelic analysis is shown in Figure S6.
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Epigenomic Analysis of Human Pancreatic Isletsdefined as 2.33 standard deviations (SD) (p = 0.01) above themedian activity of
negative controls (Heintzman et al., 2009), defined as CTCF-bound elements in
this study.
ACCESSION NUMBERS
The NCBI Gene Expression Omnibus (GEO) umbrella accession number,
which links to the individual ChIP-seq and DNase-seq data sets, is GSE23784.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and 13 tables and can be found with this article online at doi:
10.1016/j.cmet.2010.09.012.
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